# US 2019/0376069 A1 · Use of microbial consortia in the production of multi-protein complexes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0376069 A1
- Document ID: US20190376069A1
- Status: Published application
- Kind: A1
- Application number: 16/483,979
- Filed: 2018-02-06
- Published: 2019-12-12
- Earliest claimed: 2017-02-07
- Assignees: The Regents of the University of California
- Applicants: The Regents of the University of California
- Inventors: Fernando VILLARREAL; Cheemeng TAN
- Web page: https://patentgrep.com/patent/US20190376069A1

## CPC

- C12N 15/67: General methods for enhancing the expression
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C07K 14/4702: {Regulators; Modulating activity}
- C12N 1/20: Bacteria; Culture media therefor
- C12N 15/62: DNA sequences coding for fusion proteins
- C12P 21/00: Preparation of peptides or proteins (single cell protein C12N1/00)
- C40B 40/02: Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
- C40B 40/08: Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
- C40B 50/06: Biochemical methods, e.g. using enzymes or whole viable microorganisms
- C07K 2319/00: Fusion polypeptide
- C07K 2319/21: containing a His-tag
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

The present invention provides microbial cultures (referred to here as microbial consortia) comprising a plurality of microbial strains each strain comprising a different recombinant plasmid including a gene encoding a different protein involved in translation of mRNA. The protein expression level of each protein is controlled to a pre-defined level, such that the proteins are capable of forming a multi-protein complex which translates an mRNA molecule into a polypeptide in a reaction mixture.

## Claims

### Claim 1

A microbial culture comprising a plurality of microbial strains, each strain comprising a different recombinant plasmid including a gene encoding a different protein involved in translation of mRNA, wherein the protein expression level of each protein is controlled to a pre-defined level, such that the proteins are capable of forming a multi-protein complex which translates an mRNA molecule into a polypeptide in a reaction mixture.

### Claim 2 (depends on 1)

The microbial culture of claim 1, wherein the amount of each protein in the microbial culture is determined by:
(a) the density of the microbial strain in the culture,
(b) the copy number of the plasmid comprising the gene encoding the protein,
(c) the sequence of the ribosomal binding site in the gene encoding the protein; or
(d) a combination of (a), (b) and (c).

### Claim 3 (depends on 1)

The microbial culture of claim 1, wherein each gene has the same promoter.

### Claim 4 (depends on 3)

The microbial culture of claim 3, wherein the promoter is a PT7/lacO hybrid promoter.

### Claim 5 (depends on 1)

The microbial culture of claim 1, wherein the microbial culture comprises E. coli.

### Claim 6 (depends on 1)

The microbial culture of claim 1, wherein each protein includes a tag to facilitate isolation of the protein.

### Claim 7

(canceled)

### Claim 8 (depends on 1)

The microbial culture of claim 1, wherein each microbial strain comprises a single plasmid including a gene encoding a protein involved in translation of mRNA.

### Claim 9 (depends on 1)

The microbial culture of claim 1, wherein at least one strain comprises more than one plasmid including a gene encoding a protein involved in translation of mRNA.

### Claim 10 (depends on 1)

The microbial culture claim 1, wherein the proteins comprise initiation factors, elongation factors, termination/release factors, a ribosome recycling factor and tRNA-Amino acyl-transferases.

### Claim 11 (depends on 10)

The microbial culture of claim 10, wherein:
(a) the initiation factors are translational initiation factor 1, translational initiation factor 2, and translational initiation factor 3;
(b) the elongation factors are translational elongation factor G, translational elongation factor Tu, translational elongation factor Ts, and translational elongation factor 4;
(c) the termination/release factors are translational release factor 1, translational release factor 2, and translational release factor 3; and
(d) the tRNA-Amino acyl-transferases are Val-tRNA synthetase, Met-tRNA synthetase, Ile-tRNA synthetase, Thr-tRNA synthetase, Lys-tRNA synthetase, Glu-tRNA synthetase, Ala-tRNA synthetase, Asp-tRNA synthetase, Asn-tRNA synthetase, Leu-tRNA synthetase, Arg-tRNA synthetase, Cys-tRNA synthetase, Trp-tRNA synthetase, Phe-tRNA synthetase B, Pro-tRNA synthetase, Ser-tRNA synthetase, Phe-tRNA synthetase A, Gln-tRNA synthetase, Tyr-tRNA synthetase, Met-tRNA formyltransferase, Gly-tRNA synthetase B, His-tRNA synthetase, and Gly-tRNA synthetase A.

### Claim 12

A method of making a multi-protein complex which is capable of translating an mRNA molecule into a polypeptide in a reaction mixture, the method comprising:
(a) providing a microbial culture comprising a plurality of microbial strains, each strain comprising a different recombinant plasmid including a gene encoding a different protein involved in translation of mRNA, wherein the protein expression level of each protein is controlled to a pre-defined level, such that the proteins are capable of forming a multi-protein complex; and
(b) simultaneously isolating the proteins from the microbial culture, thereby forming the multi-protein complex.

### Claim 13 (depends on 12)

The method of claim 12, wherein the microbial culture comprises E. coli.

### Claim 14 (depends on 12)

The method of claim 12, wherein each protein includes a tag to facilitate isolation of the protein.

### Claim 15 (depends on 14)

The method of claim 14, wherein the tag is a poly His tag.

### Claim 16 (depends on 12)

The method of claim 12, wherein the proteins comprise initiation factors, elongation factors, termination/release factors, a ribosome recycling factor and tRNA-Amino acyl-transferases.

### Claim 17 (depends on 16)

The method of claim 16, wherein:
(a) the initiation factors are translational initiation factor 1, translational initiation factor 2, and translational initiation factor 3;
(b) the elongation factors are translational elongation factor G, translational elongation factor Tu, translational elongation factor Ts, and translational elongation factor 4;
(c) the termination/release factors are translational release factor 1, translational release factor 2, and translational release factor 3; and
(d) the tRNA-Amino acyl-transferases are Val-tRNA synthetase, Met-tRNA synthetase, Ile-tRNA synthetase, Thr-tRNA synthetase, Lys-tRNA synthetase, Glu-tRNA synthetase, Ala-tRNA synthetase, Asp-tRNA synthetase, Asn-tRNA synthetase, Leu-tRNA synthetase, Arg-tRNA synthetase, Cys-tRNA synthetase, Trp-tRNA synthetase, Phe-tRNA synthetase B, Pro-tRNA synthetase, Ser-tRNA synthetase, Phe-tRNA synthetase A, Gln-tRNA synthetase, Tyr-tRNA synthetase, Met-tRNA formyltransferase, Gly-tRNA synthetase B, His-tRNA synthetase, and Gly-tRNA synthetase A.

### Claim 18

A method of translating an mRNA molecule into a polypeptide, the method comprising:
(a) providing a microbial culture comprising a plurality of microbial strains, each strain comprising a different recombinant plasmid comprising a gene encoding a different protein involved in translation of mRNA, wherein the protein expression level of each protein is controlled to a pre-defined level, such that the proteins are capable of forming a multi-protein complex which translates an mRNA molecule into a polypeptide in a reaction mixture;
(b) simultaneously isolating the proteins from the microbial culture, thereby forming the multi-protein complex;
(c) forming a reaction mixture comprising the multi-protein complex, amino acids, ribosomes, and the mRNA molecule or a DNA molecule encoding the mRNA;
(d) incubating the reaction mixture under conditions suitable for translation of the mRNA molecule into a polypeptide; and
(e) isolating the polypeptide.

### Claim 19 (depends on 18)

The method of claim 18, wherein the multi-protein complex comprises initiation factors, elongation factors, termination/release factors, a ribosome recycling factor and tRNA-Amino acyl-transferases.

### Claim 20 (depends on 19)

The method of claim 19, wherein:
(a) the initiation factors are translational initiation factor 1, translational initiation factor 2, and translational initiation factor 3;
(b) the elongation factors are translational elongation factor G, translational elongation factor Tu, translational elongation factor Ts, and translational elongation factor 4;
(c) the termination/release factors are translational release factor 1, translational release factor 2, and translational release factor 3; and
(d) the tRNA-Amino acyl-transferases are Val-tRNA synthetase, Met-tRNA synthetase, Ile-tRNA synthetase, Thr-tRNA synthetase, Lys-tRNA synthetase, Glu-tRNA synthetase, Ala-tRNA synthetase, Asp-tRNA synthetase, Asn-tRNA synthetase, Leu-tRNA synthetase, Arg-tRNA synthetase, Cys-tRNA synthetase, Trp-tRNA synthetase, Phe-tRNA synthetase B, Pro-tRNA synthetase, Ser-tRNA synthetase, Phe-tRNA synthetase A, Gln-tRNA synthetase, Tyr-tRNA synthetase, Met-tRNA formyltransferase, Gly-tRNA synthetase B, His-tRNA synthetase, and Gly-tRNA synthetase A.

### Claim 21 (depends on 18)

The method of claim 18, wherein each protein includes a tag to facilitate isolation of the protein and the step of isolating the polypeptide is carried out by contacting the reaction mixture comprising the polypeptide with a solid support that specifically binds the tag, thereby separating the polypeptide from the proteins involved in translation of mRNA.

### Claim 22

(canceled)
